The Technical AnalystExchange: PNK Industry: Drug Manufacturers
Vivos Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-7.12% $0.200
America/New_York / 3 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 77.86 mill |
| EPS: | -0.0100 |
| P/E: | -19.97 |
| Earnings Date: | May 01, 2024 |
| SharesOutstanding: | 389.89 mill |
| Avg Daily Volume: | 1.095 mill |
| RATING 2024-05-03 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -19.97 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -19.97 | industry: PE -6.21 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.0026 (-98.72%) $-0.197 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.191 - 0.209 ( +/- 4.51%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-11-13 | Korenko Michael K | Buy | 100 000 | Common Stock |
| 2023-10-18 | Korenko Michael K | Buy | 100 000 | Common Stock |
| 2023-03-24 | Pollack Michael H | Sell | 16 000 | Common Stock |
| 2022-12-15 | Korenko Michael K | Buy | 100 000 | Common Stock |
| 2022-11-17 | Korenko Michael K | Buy | 200 000 | Common Stock |
| INSIDER POWER |
|---|
| 94.75 |
| Last 83 transactions |
| Buy: 210 253 762 | Sell: 27 739 077 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.200 (-7.12% ) |
| Volume | 6.51 mill |
| Avg. Vol. | 1.095 mill |
| % of Avg. Vol | 594.47 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RDGL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RDGL
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Latest Press Releases
Latest News
